Synergistic Combination of Quercetin and Mafosfamide in Treatment of Bladder Cancer Cells
Molecules · 31.10.2024 · 29 (21) · 5176
DOI: 10.3390/molecules29215176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 31.10.2024. Verfasst von Carmela Spagnuolo und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Research Council, Institute of Food Sciences, 83100 Avellino, Italy. Hauptthemen laut MEDLINE: Quercetin, Urinary Bladder Neoplasms, Drug Synergism, Apoptosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CNR project NUTRAGE, CNR grant FUNZIONAMENTO ISA, CNR project.
Abstract (Originalsprache)
Bladder cancer, which has a rising incidence, is the 10th most common cancer. The transitional cell carcinoma histotype is aggressive and often current therapies are ineffective. We investigated the anti-proliferative effect of quercetin, a natural flavonoid, in combination with the alkylating agent mafosfamide (MFA) on two human bladder cancer cell lines, namely RT112 and J82, representing the progression from low-grade to high-grade tumors, respectively. In both cell types, the combined treatment led to a synergic reduction in cell viability confirmed by a combination index of less than one, though different biological responses were noted. In J82 cells, MFA alone and, to a lesser extent, with quercetin caused cell cycle arrest in the G2/M phase, but only the combined treatment triggered apoptotic cell death. In contrast, in RT112 cells, quercetin induced autophagy, evidenced by the autophagosome formation and the increase in LC-3 lipidation. Interestingly, the synergistic effect was observed only when cells were pre-treated with MFA for 24 h before adding quercetin, not in the reverse order. This suggests that quercetin may help overcome MFA resistance to apoptosis. Although further studies are needed, investigating the combined effects of quercetin and MFA could help elucidate the mechanisms of drug resistance in bladder cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Research Council, Institute of Food Sciences, 83100 Avellino, Italy.
- Oncology Unit, Hospital "Andrea Tortora", ASL Salerno, 84016 Pagani, Italy.
- Associazione O.R.A. ETS, Oncology Research Assistance, 84134 Salerno, Italy.
ORCID-Profile: Carmela Spagnuolo, Stefania Moccia, Gian Luigi Russo
Förderung
- CNR project NUTRAGE
- CNR grant FUNZIONAMENTO ISA
- CNR project
Zitieren
APA
Spagnuolo, C., Mautone, F., Meola, A. M. I., Moccia, S., Di Lorenzo, G., Buonerba, C., & Russo, G. L. (2024). Synergistic Combination of Quercetin and Mafosfamide in Treatment of Bladder Cancer Cells. Molecules, 29(21), 5176. https://doi.org/10.3390/molecules29215176
Vancouver
Spagnuolo C, Mautone F, Meola AMI, Moccia S, Di Lorenzo G, Buonerba C, et al. Synergistic Combination of Quercetin and Mafosfamide in Treatment of Bladder Cancer Cells. Molecules. 2024;29(21):5176. doi:10.3390/molecules29215176
BibTeX
@article{Spagnuolo2024,
author = {Spagnuolo, Carmela and Mautone, Francesco and Meola, Anna Maria Iole and Moccia, Stefania and Di Lorenzo, Giuseppe and Buonerba, Carlo and Russo, Gian Luigi},
title = {Synergistic Combination of Quercetin and Mafosfamide in Treatment of Bladder Cancer Cells},
journal = {Molecules},
year = {2024},
volume = {29},
number = {21},
pages = {5176},
doi = {10.3390/molecules29215176}
}
EUVIMED